Reviving immune responsiveness after tuberculosis
The findings could reduce the illness and mortality that occur after TB has been successfully treated.
Read More
Bacteriophages: antibiotic resistant tuberculosis’ worst nightmare
In the shadow of the COVID-19 pandemic, another silent killer, tuberculosis (TB), loomed.
Read More
Researchers identify two distinct tuberculosis subtypes – one has better prognosis than the other
The study of the human immune response to tuberculosis revealed an approach that can lead to the development of personalized therapies.
Read More
Tuberculosis induces premature cellular aging
It’s possible that premature cellular aging in TB is one reason why survivors have a three-fold increased risk of mortality.
Read More
Tackling tuberculosis both at home and abroad
Tuberculosis knows no boundaries. It is a life-threatening disease in the United States and around the world – especially for children. Although there has been
Read More
Starke lends expertise to national advisory committee to end tuberculosis
For the last three decades Dr. Jeffrey Starke, professor of pediatrics-infectious diseases at Baylor College of Medicine, has spent his career treating children infected with
Read More
Helping Swaziland’s children fight tuberculosis
Beyond the ribbon cutting and celebration of opening a new state-of-the-art facility for the Global Tuberculosis Program at Texas Children’s Hospital and Baylor College of
Read More